Amman Bradford K. 4
4 · Vivos Therapeutics, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20$2.38/sh+15,000$35,700→ 31,667 totalExercise: $2.38Exp: 2029-06-20→ Common Stock (15,000 underlying)
Holdings
- 80
Common Stock
Footnotes (1)
- [F1]On June 20, 2024 (the "Grant Date"), the Reporting Person received a grant of 15,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028.